43 related articles for article (PubMed ID: 9311649)
1. Immunoblot with cerebrospinal fluid from patients with neurocysticercosis using antigen from cysticerci of Taenia solium and Taenia crassiceps.
Vaz AJ; Nunes CM; Piazza RM; Livramento JA; Da Silva MV; Nakamura PM; Ferreira AW
Am J Trop Med Hyg; 1997 Sep; 57(3):354-7. PubMed ID: 9311649
[TBL] [Abstract][Full Text] [Related]
2.
García LCA; Pérez MG; Ancarola ME; Rosenzvit MC; Cucher MA
Parasitology; 2022 Nov; 149(13):1775-1780. PubMed ID: 36165285
[No Abstract] [Full Text] [Related]
3. Are alternative sources of parasitic (cysticercal) antigens necessary for diagnosis of neurocysticercosis?
Katti MK
J Clin Microbiol; 2000 Sep; 38(9):3524-5. PubMed ID: 11203335
[No Abstract] [Full Text] [Related]
4. Experimental animal models and their use in understanding cysticercosis: A systematic review.
Sitali MC; Schmidt V; Mwenda R; Sikasunge CS; Mwape KE; Simuunza MC; da Costa CP; Winkler AS; Phiri IK
PLoS One; 2022; 17(7):e0271232. PubMed ID: 35853079
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific suppression of cultured lymphocytes from patients with neurocysticercosis.
Bueno EC; Vaz AJ; Machado LR; Livramento JA; Avila SL; Ferreira AW
Clin Exp Immunol; 2001 Nov; 126(2):304-10. PubMed ID: 11703375
[TBL] [Abstract][Full Text] [Related]
6. The muscle and neural architecture of
Calderón-Gallegos A; Tapia-Rodríguez M; Estrada K; Rios-Valencia DG; de la Torre P; Castellanos-de Oteyza N; Morales MA; Bobes RJ; Laclette JP
Front Cell Infect Microbiol; 2024; 14():1415162. PubMed ID: 38919702
[No Abstract] [Full Text] [Related]
7. Chronic administration of cryptolepine nanoparticle formulation alleviates seizures in a neurocysticercosis model.
Mante PK; Adomako NO; Antwi P; Kusi-Boadum NK
Curr Res Pharmacol Drug Discov; 2021; 2():100040. PubMed ID: 34909669
[TBL] [Abstract][Full Text] [Related]
8. Differential Protein Expression of
Jiménez L; Díaz-Zaragoza M; Hernández M; Navarro L; Hernández-Ávila R; Encarnación-Guevara S; Ostoa-Saloma P; Landa A
Pathogens; 2023 May; 12(5):. PubMed ID: 37242348
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Treatment with the Combination of Nitazoxanide and Flubendazole Induces Gluconeogenesis and Protein Catabolism in Taenia crassiceps cysticerci.
Lima NF; Picanço GA; Costa TL; de Souza Lino Junior R; Vinaud MC
Acta Parasitol; 2021 Mar; 66(1):98-103. PubMed ID: 32761323
[TBL] [Abstract][Full Text] [Related]
10. Mimotope-based antigens as potential vaccine candidates in experimental murine cysticercosis.
Manhani MN; Tilelli CQ; Ribeiro VDS; Goulart LR; Costa-Cruz JM
Parasitology; 2020 Oct; 147(12):1330-1337. PubMed ID: 32660680
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic evaluation of experimental murine neurocysticercosis after treatment with albendazole/nitazoxanide combination.
Sampaio GA; Zago LV; de Lima NF; Picanço GA; Lino Júnior RS; Vinaud MC
Parasitology; 2020 Jun; 147(7):822-827. PubMed ID: 32234089
[TBL] [Abstract][Full Text] [Related]
12. IgY antibody and human neurocysticercosis: a novel approach on immunodiagnosis using
Carrara GMP; Silva GB; Faria LS; Nunes DS; Ribeiro VS; Lopes CA; Gonçalves-Pires MDRF; Santos MM; Borges IP; Ferreira-Junior Á; Ávila VMR; Costa-Cruz JM
Parasitology; 2020 Feb; 147(2):240-247. PubMed ID: 31603062
[TBL] [Abstract][Full Text] [Related]
13. A gel-free proteomic analysis of Taenia solium and Taenia crassiceps cysticerci vesicular extracts.
da Costa GCV; Peralta RHS; Kalume DE; Alves ALGM; Peralta JM
Parasitol Res; 2018 Dec; 117(12):3781-3790. PubMed ID: 30215138
[TBL] [Abstract][Full Text] [Related]
14. Development of the multi-epitope chimeric antigen rqTSA-25 from Taenia saginata for serological diagnosis of bovine cysticercosis.
Guimarães-Peixoto RPM; Pinto PSA; Santos MR; Zilch TJ; Apolinário PF; Silva-Júnior A
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006371. PubMed ID: 29649259
[TBL] [Abstract][Full Text] [Related]
15. In vivo treatment with nitazoxanide induces anaerobic metabolism in experimental intraperitoneal cysticercosis.
Nasareth JM; Fraga CM; Lima NF; Picanço GA; Costa TL; Lino-Junior RS; Vinaud MC
Parasitol Res; 2017 Nov; 116(11):3037-3041. PubMed ID: 28914356
[TBL] [Abstract][Full Text] [Related]
16. EXPERIMENTAL SUBCUTANEOUS CYSTICERCOSIS BY Taenia crassiceps IN BALB/c AND C57BL/6 MICE.
Pereira ÍM; Lima SB; Freitas Ade A; Vinaud MC; Junior Rde S
Rev Inst Med Trop Sao Paulo; 2016 Jul; 58():55. PubMed ID: 27410915
[TBL] [Abstract][Full Text] [Related]
17. Cysticercosis immunodiagnosis using 18- and 14-kilodalton proteins from Taenia crassiceps cysticercus antigens obtained by immunoaffinity chromatography.
Espíndola NM; Iha AH; Fernandes I; Takayanagui OM; Machado Ldos R; Livramento JA; Mendes Maia AA; Peralta JM; Vaz AJ
J Clin Microbiol; 2005 Jul; 43(7):3178-84. PubMed ID: 16000432
[TBL] [Abstract][Full Text] [Related]
18. Use of Taenia crassiceps cysticercus antigen preparations for detection of antibodies in cerebrospinal fluid samples from patients with neurocysticercosis (Taenia solium).
Pardini AX; Peralta RH; Vaz AJ; Machado Ldos R; Peralta JM
Clin Diagn Lab Immunol; 2002 Jan; 9(1):190-3. PubMed ID: 11777854
[TBL] [Abstract][Full Text] [Related]
19. Serodiagnosis of human cysticercosis by using antigens from vesicular fluid of Taenia crassiceps cysticerci.
Bueno EC; Snege M; Vaz AJ; Leser PG
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1140-4. PubMed ID: 11687454
[TBL] [Abstract][Full Text] [Related]
20. Cysticercus antigens in cerebrospinal fluid samples from patients with neurocysticercosis.
Pardini AX; Vaz AJ; Dos Ramos Machado L; Livramento JA
J Clin Microbiol; 2001 Sep; 39(9):3368-72. PubMed ID: 11526181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
